Sophoricoside improved Crohn's disease-like colitis by inhibiting intestinal epithelial cell apoptosis through PI3K/AKT signaling
Authors:
Open Access
- 16 March 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 131, 111886
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 41 references indexed in Scilit:
- Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and TherapeuticsDigestive Diseases and Sciences, 2023
- Oral administration of sophoricoside (SOP) inhibits neuronal damage and neuroinflammation to curb neurodegeneration in Parkinson's diseaseChemico-Biological Interactions, 2023
- Melatonin-mediated MT2 attenuates colitis induced by dextran sodium sulfate via PI3K/AKT/Nrf2/SIRT1/RORα/NF-κB signaling pathwaysInternational Immunopharmacology, 2021
- Sophoricoside from Sophora japonica ameliorates allergic asthma by preventing mast cell activation and CD4+ T cell differentiation in ovalbumin-induced miceBiomedicine & Pharmacotherapy, 2021
- Repression of deoxynivalenol-triggered cytotoxicity and apoptosis by mannan/β-glucans from yeast cell wall: Involvement of autophagy and PI3K-AKT-mTOR signaling pathwayInternational Journal of Biological Macromolecules, 2020
- The potential health benefits of the isoflavone glycoside genistinArchives of Pharmacal Research, 2020
- Cigarette smoking is associated with intestinal barrier dysfunction in the small intestine but not in the large intestine of miceJournal of Crohn's and Colitis, 2014
- Intestinal Permeability Defects: Is It Time to Treat?Clinical Gastroenterology and Hepatology, 2013
- Importance of disrupted intestinal barrier in inflammatory bowel diseasesInflammatory Bowel Diseases, 2011
- Localized colonic inflammation increases cytokine levels in distant small intestinal segments in the ratLife Sciences, 2006